Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis (2015)
- Authors:
- Autor USP: SHINJO, SAMUEL KATSUYUKI - FM
- Unidade: FM
- DOI: 10.1007/s10067-014-2757-1
- Subjects: ANALGESIA; FÁRMACOS; OSTEOARTRITE DO JOELHO (TERAPIA); ANTI-INFLAMATÓRIOS NÃO ESTEROIDES
- Language: Inglês
- Imprenta:
- Source:
- Título: Clinical rheumatology
- ISSN: 0770-3198
- Volume/Número/Paginação/Ano: v. 34, n. 8, p. 1455-1462, 2015
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
PROVENZA, José Roberto et al. Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis. Clinical rheumatology, v. 34, n. 8, p. 1455-1462, 2015Tradução . . Disponível em: https://doi.org/10.1007/s10067-014-2757-1. Acesso em: 29 dez. 2025. -
APA
Provenza, J. R., Shinjo, S. K., Silva, J. M., Peron, C. R. G. S., Rocha, F. A. C., Bonfá, E., & Silva, C. A. (2015). Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis. Clinical rheumatology, 34( 8), 1455-1462. doi:10.1007/s10067-014-2757-1 -
NLM
Provenza JR, Shinjo SK, Silva JM, Peron CRGS, Rocha FAC, Bonfá E, Silva CA. Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis [Internet]. Clinical rheumatology. 2015 ; 34( 8): 1455-1462.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1007/s10067-014-2757-1 -
Vancouver
Provenza JR, Shinjo SK, Silva JM, Peron CRGS, Rocha FAC, Bonfá E, Silva CA. Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis [Internet]. Clinical rheumatology. 2015 ; 34( 8): 1455-1462.[citado 2025 dez. 29 ] Available from: https://doi.org/10.1007/s10067-014-2757-1 - Desfechos da gestação em pacientes com dermatomiosite e polimiosite
- Spontaneous pneumomediastinum in dermatomyositis: a case series and literature review
- Mycophenolate mofetil in patients with refractory systemic autoimmune myopathies: case series
- Patients with pure dermatomyositis/polymyositis and anti-PM/Scl autoantibody resembling anti-synthetase syndrome
- Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?
- Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study
- Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study
- COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies
- COVID-19 breakthrough infections in type 1 diabetes mellitus: a cross-sectional study by the COVID-19 Vaccination in Autoimmune Diseases (COVAD) Group
- Breaking the diagnosis. [Editorial]: ankylosing spondylitis evidenced by cervical fracture following spine manipulation
Informações sobre o DOI: 10.1007/s10067-014-2757-1 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
